(1)
Rosenblum, PhD, A.; Cruciani, MD, PhD, R. A.; Strain, MD, E. C.; Cleland, PhD, C. M.; Joseph, PhD, H.; Magura, PhD, CSW, S.; Marsch, PhD, L. A.; McNicholas, MD, PhD, L. F.; Savage, MD, MS, S. R.; Sundaram, BA, A.; Portenoy, MD, R. K. Sublingual buprenorphine/Naloxone for Chronic Pain in at-Risk Patients: Development and Pilot Test of a Clinical Protocol. J of Opioid Management 2012, 8.